These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8424094)
1. Stage of tumor progression, progressor agents, and human risk. Pitot HC; Dragan YP Proc Soc Exp Biol Med; 1993 Jan; 202(1):37-43. PubMed ID: 8424094 [No Abstract] [Full Text] [Related]
2. Re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995. Ames BN; Gold LS Cancer Res; 1996 Sep; 56(18):4267-9; author reply 4272-4. PubMed ID: 8797604 [No Abstract] [Full Text] [Related]
3. Incorporating cell proliferation in quantitative cancer risk assessment: approaches, issues, and uncertainties. Chen C; Farland W Prog Clin Biol Res; 1991; 369():481-99. PubMed ID: 1946541 [No Abstract] [Full Text] [Related]
4. Facts and theories concerning the mechanisms of carcinogenesis. Pitot HC; Dragan YP FASEB J; 1991 Jun; 5(9):2280-6. PubMed ID: 1860619 [TBL] [Abstract][Full Text] [Related]
5. The instability of tumor promotion in relation to human cancer risk. Pitot HC; Dragan YP Prog Clin Biol Res; 1995; 391():21-38. PubMed ID: 8532718 [No Abstract] [Full Text] [Related]
6. Comparisons of human cancer potency projections for dieldrin based on human data with those based on animal data. Sielken RL; Stevenson DE Prog Clin Biol Res; 1992; 374():295-319. PubMed ID: 1620708 [No Abstract] [Full Text] [Related]
7. Pineal influences on tumor. Lapin V Prog Brain Res; 1979; 52():523-33. PubMed ID: 232927 [No Abstract] [Full Text] [Related]
8. Introduction: is there a boundary between promotion and progression? Sudilovsky O Basic Life Sci; 1991; 57():1-2. PubMed ID: 1814280 [No Abstract] [Full Text] [Related]
9. U.S. Japan Seminar on molecular mechanisms of initiation, promotion progression. Benedict WF; Harris CC; Fuijiki H; Toyoshima K Cancer Res; 1990 Nov; 50(21):7085-8. PubMed ID: 2208178 [No Abstract] [Full Text] [Related]
10. [Progression of tumors: etiologic, morphologic and molecular-biological aspects]. Turosov VS Arkh Patol; 1992; 54(7):5-14. PubMed ID: 1471943 [TBL] [Abstract][Full Text] [Related]
11. New in vitro approaches to explore cellular and molecular events related to carcinogenesis. Fimognari C; Nüsse M; Forti GC; Hrelia P Pharmacol Res; 2000 Apr; 41(4):385-90. PubMed ID: 10704260 [No Abstract] [Full Text] [Related]
12. [Kinetics and free-radical mechanisms of tumor growth]. Emanuél NM Izv Akad Nauk SSSR Biol; 1974; (6):773-84. PubMed ID: 4376158 [No Abstract] [Full Text] [Related]
14. The correlation of experimental carcinogenesis and cancer in man. Boyland E Prog Exp Tumor Res; 1969; 11():222-34. PubMed ID: 4888943 [No Abstract] [Full Text] [Related]
15. Multistage models and primary prevention of cancer. Day NE; Brown CC J Natl Cancer Inst; 1980 Apr; 64(4):977-89. PubMed ID: 6929006 [TBL] [Abstract][Full Text] [Related]
16. [Identification of human carcinogenic risks in IARC monographs]. Vainio H; Wilbourn JD; Sasco AJ; Partensky C; Gaudin N; Heseltine E; Eragne I Bull Cancer; 1995; 82(5):339-48. PubMed ID: 7626841 [TBL] [Abstract][Full Text] [Related]
17. Limitations and inconsistencies in the approaches to cancer prevention. Tomatis L Teratog Carcinog Mutagen; 1995-1996; 15(6):277-82. PubMed ID: 8732879 [No Abstract] [Full Text] [Related]
18. Natural carcinogens and dioxin. Ames BN Sci Total Environ; 1991 May; 104(1-2):159-66. PubMed ID: 1871587 [TBL] [Abstract][Full Text] [Related]
19. The nature of organ specificity in chemical carcinogenesis. Rice JM; Frith CH Basic Life Sci; 1983; 24():1-22. PubMed ID: 6860259 [No Abstract] [Full Text] [Related]